Ruderman, Irene
Smith, Edward R.
Toussaint, Nigel D.
Hewitson, Tim D.
Holt, Stephen G.
Funding for this research was provided by:
Amgen Australia- unrestricted investigator initiated research grant
Article History
Received: 7 February 2018
Accepted: 27 April 2018
First Online: 15 May 2018
Ethics approval and consent to participate
: Research performed in accordance with the Declaration of Helsinki. The study was approved by the Melbourne Health Human Research Ethics Committee (#HREC 2015.180). Written informed consent was obtained from all participants at study commencement.
: ERS owns stock in Calciscon. ERS received research funding from Amgen, Baxter and Sanofi. NDT has received honoraria, travel support and research funding from Amgen, Shire and Sanofi. SGH has research funding, honoraria, travel support and from Amgen, Astra-Zenica, Baxter and Sanofi. TDH and IR declares that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.